Results 141 to 150 of about 28,079 (244)

Microarray Compound Screening (μARCS) to Identify Inhibitors of HIV Integrase

, 2002
Caroline A. David, Tim Middleton, Debra Montgomery, Hock Ben Lim, Warren M. Kati, Akhter Molla, Xiaoling Xuei, Usha Warrior, James L. Kofron, David J. Burns   +9 more
openalex   +1 more source

Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps. [PDF]

Clin Pharmacokinet, 2019
van der Galiën R, Ter Heine R, Greupink R, Schalkwijk SJ, van Herwaarden AE, Colbers A, Burger DM.   +6 more
europepmc   +1 more source

Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations. [PDF]

Viruses, 2018
Charpentier C, Descamps D.
europepmc   +1 more source

Integrase inhibitors in the treatment of HIV-1 infection [PDF]

, 2010
William G. Powderly
openalex   +1 more source

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

, 2007
John M. Murray, Sean Emery, Anthony D. Kelleher, Matthew Law, Joshua Chen, Daria J. Hazuda, Bach‐Yen Nguyen, Hedy Teppler, David A. Cooper   +8 more
openalex   +1 more source

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961) [PDF]

, 2010
Joseph J. Eron, JM Livrozet, Philippe Morlat, Adriano Lazzarin, Christine Katlama, Trevor Hawkins, Tamio Fujiwara, Robert L. Cuffe, Cindy Vavro, Julio Montes Santiago, Mounir Ait‐Khaled, Sherene Min, JM Yeo   +12 more
openalex   +1 more source

Activity of Elvitegravir, a Once‐Daily Integrase Inhibitor, against Resistant HIV Type 1: Results of a Phase 2, Randomized, Controlled, Dose‐Ranging Clinical Trial [PDF]

, 2010
Andrew Zolopa, Daniel S Berger, Harry Lampiris, Lijie Zhong, Steven L. Chuck, Jeffrey Enejosa, Brian P. Kearney, Andrew Cheng   +7 more
openalex   +1 more source

Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors [PDF]

, 2011
Horrick Sharma, Shivaputra A. Patil, Tino W. Sanchez, Nouri Neamati, Raymond F. Schinazi, John K. Buolamwini   +5 more
openalex   +1 more source

The Terminal (Catalytic) Adenosine of the HIV LTR Controls the Kinetics of Binding and Dissociation of HIV Integrase Strand Transfer Inhibitors

, 2008
David R. Langley, Himadri Samanta, Zeyu Lin, Michael Walker, Mark Krystal, Ira B. Dicker   +5 more
openalex   +1 more source

HIV-1 integrase inhibitor T30177 forms a stacked dimeric G-quadruplex structure containing bulges [PDF]

, 2011
Vineeth Thachappilly Mukundan, Ngoc Quang, Anh Tuân Phan   +2 more
openalex   +1 more source